Human papillomavirus (HPV) information needs: a theoretical framework

Human papillomavirus (HPV) information needs: a theoretical framework

BACKGROUND With the introduction of human papillomavirus (HPV) testing and vaccination in the UK, health professionals will start to receive questions about the virus from their patients. This study aimed to identify the key questions about HPV that British women will ask when considering having an HPV test or vaccination. METHODS Face-to-face interviews were carried out with 21 women to disc...

Human papillomavirus: HPV information for clinicians.

Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology.

OBJECTIVES Testing for human papillomavirus (HPV) infection has recently been introduced into cervical screening programmes. We investigated (1) barriers to accessing and absorbing information and (2) factors that influence information needs among women undergoing HPV tests. METHODS In-depth interviews were conducted with 27 women who had HPV tests performed in a colposcopy clinic as part of ...

Human papillomavirus (HPV) vaccines

Kinoshita et al. 2014 48 patients (from same clinic as above and largely overlapping time period). 18 fulfilling the diagnostic criteria for CRPS-1. Abstract /Kinoshita et al, 2014 17 patients from an unknown time period. -Kinoshita et al, 2014 17 patients from an unknown time period. Letter to the editor / 2 adolescents Both patients fulfilled the fibromyalgia criteria and were 22 Richards et ...

Human papillomavirus and HPV vaccines: a review.

Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70% of all cervical cancers. Types 6 and 11 do not contribute to the incidence of high-grade dysplasias (precancerous lesions) or cervical cancer...